The shelf registration is a routine replacement filing, but the company's going concern warning and small public float ($25.6M) mean any actual offering will be limited to about $8.5M per 12-month period under I.B.6 rules. Monitor for a prospectus supplement that would trigger an actual offering and reveal pricing and dilution terms. The company's cash position and burn rate from the next 10-Q will determine whether this shelf is used as a lifeline.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Oct 30 $1.16entry
- T+1 · 2d ago +3.45%α +3.15% · $1.20
- T+3 · todayOpen
- T+5 · tomorrow Pending
- T+20 · in 26d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Bionano Genomics filed Amendment No. 1 to its S-3 shelf registration statement, registering up to $400 million in securities (common stock, preferred stock, debt securities, warrants, units). The filing replaces a prior shelf that expires November 6, 2026 and carries forward $148.1 million of unsold securities from that prior shelf. The company's public float is $25.6 million, and due to its small float, it is limited under General Instruction I.B.6 to selling no more than one-third of that float ($8.5 million) in any 12-month period in primary offerings. The filing signals potential future dilution, but the actual amount sellable is tightly constrained by the float limitation.
Key Financial Metrics
Key Facts
- Shelf registration of up to $400,000,000 in securities (common, preferred, debt, warrants, units).
- Public float is $25,582,638.72 based on 13,979,584 non-affiliate shares at a $1.83 reference price.
- Under General Instruction I.B.6, the company cannot sell more than one-third of its public float ($8.5 million) in primary offerings in any 12-month period while float stays below $75 million.
- The filing carries forward $148,146,961.18 of unsold securities from the prior S-3 (File No. 333-270459).
- The company has incurred recurring net losses and its auditor's report includes a going concern explanatory paragraph.
- The company's common stock closed at $1.21 per share on October 28, 2026.
- During the prior 12 months, the company sold approximately $5,944,305 of securities under General Instruction I.B.6.
Financial Impact
Up to $400 million shelf registered, but actual near-term sellable amount is capped at roughly $8.5 million (one-third of $25.6 million public float) under I.B.6 constraints.
Risk Factors
- Potential dilution from future offerings under the shelf, though constrained by the I.B.6 float limitation.
- Going concern risk highlighted in the auditor's report and in the risk factors.
- Company has a history of recurring net losses and negative cash flows, raising doubt about its ability to continue as a going concern.
- If the company cannot raise sufficient capital, it may need to curtail operations, liquidate, or cease operations.
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3/A Filing (Primary) | 0001193125-26-442017 |
| Document: bngo-exfiling_fees.htm | 0001193125-26-442017 |
| Document: bngo-ex23_1.htm | 0001193125-26-442017 |
| Document: 0001193125-26-442017-index-headers.html | 0001193125-26-442017 |
| Document: 0001193125-26-442017-index.html | 0001193125-26-442017 |
| Document: 0001193125-26-442017.txt | 0001193125-26-442017 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 4d ago | S-3/A | $1.16 | awaiting T+5 | awaiting T+5 | $1.19 (−2.59%) |
Oct 27, 2026 7d ago | S-1 | $1.21 | awaiting T+5 | awaiting T+5 | $1.19 (−1.24%) |
Oct 19, 2026 16d ago | SC 13G | $1.22 $1.16 | ▼ −4.92% | ▼ −4.77% | $1.19 (−2.46%) |
Sep 14, 2026 7w ago | Press Release | $1.33 $1.83 | ▲ +37.59% | ▲ +37.49% | $1.19 (−10.53%) |
Sep 14, 2026 7w ago | 8-K | $1.33 $1.83 | ▲ +37.59% | ▲ +37.49% | $1.19 (−10.53%) |
Aug 10, 2026 12w ago | 8-K | $1.19 $1.18 | ▼ −0.84% | ▼ −0.44% | $1.19 (+0.00%) |
Jun 5, 2026 21w ago | 8-K | $1.17 $1.16 | ▲ +0.85% | ▲ +2.97% | $1.19 (−1.71%) |
May 28, 2026 22w ago | 8-K | $1.25 $1.30 | ▲ +4.00% | ▲ +4.05% | $1.19 (−4.80%) |
Mar 23, 2026 32w ago | Press Release | $1.18 $1.17 | ▲ +0.85% | ▲ +0.42% | $1.19 (−0.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers